Skip to main content
SpringerLink
Log in

Estimation of risk for major bleeding in native kidney biopsies in patients with multiple risk factors

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Background and aims

Individuals undergoing kidney biopsy are increasingly older and may have concurrent illnesses that cause deranged hematological and renal parameters that are associated with post-biopsy bleeding. We aimed to develop a clinical risk model to quantify bleeding risks in high-risk individuals with multiple risk factors.

Methods

Single-center retrospective cohort study of consecutive adults with serum creatinine ≥ 2 mg/dL (176 µmol/L) and had ultrasound-guided percutaneous native kidney biopsies between June 2011 and July 2015 in our tertiary referral center. The primary outcome was major bleeding, defined as need for red cell transfusion, radiological or surgical intervention, or if bleeding led to death within 7 days after kidney biopsy.

Results

Among 184 native kidney biopsies with serum creatinine ≥ 2 mg/dL, median age was 54.1 years and eGFR was 18.8 ml/min/1.73 m2. Major bleeding occurred in 19 biopsies (10.3%). Multivariate analysis accounting for age, weight, hemoglobin, platelet, prothrombin time and urea found that higher hemoglobin (adjusted OR 0.51, 95% CI 0.33–0.79, p = 0.003) and platelet (adjusted OR 0.99, 95% CI 0.98–0.99, p = 0.01) were independently associated with reduced major bleeding. A risk model that included (1) age ≥ 62 years old, (2) hemoglobin < 10 g/dL and (3) platelets ≤ 216 × 109/L as categorical variables predicted major bleeding post-biopsy.

Conclusion

We developed a risk model that included multiple risk factors to quantify bleeding risks in native kidney biopsies with renal impairment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney APS, Briggs D et al (2000) Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study. Am J Kidney Dis 35(1):157–165

    Article  CAS  Google Scholar 

  2. Gan L, Zuo L (2015) Current ESRD burden and its future trend in Beijing, China. Clin Nephrol 83(7 Suppl 1):17–20

    Article  Google Scholar 

  3. Lim CC, Huang H, Chin YM, Teng WL, Woo KT (2019) Kidney biopsy in the elderly: Safety and strategies to prevent uremic bleeding. Nephrology (Carlton) 24:876

    Article  Google Scholar 

  4. Cunningham A, Benediktsson H, Muruve DA, Hildebrand AM, Ravani P (2018) Trends in biopsy-based diagnosis of kidney disease: a population study. Can J Kidney Health Dis 5:2054358118799690

    Article  Google Scholar 

  5. Corapi KM, Chen JL, Balk EM, Gordon CE (2012) Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis 60(1):62–73

    Article  Google Scholar 

  6. Lim CC, Siow B, Choo JC, Chawla M, Chin YM, Kee T, Lee PH, Foo M, Tan CS (2019) Desmopressin for the prevention of bleeding in percutaneous kidney biopsy: efficacy and hyponatremia. Int Urol Nephrol 51:1–10

    Article  CAS  Google Scholar 

  7. Akaike H (1974) A new look at the statistical model identification. IEEE Trans Autom Control 19(6):716–723

    Article  Google Scholar 

  8. Davidson JC, Rahim S, Hanks SE, Patel IJ, Tam AL, Walker TG, Weinberg I, Wilkins LR, Sarode R (2019) Society of Interventional Radiology Consensus Guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions—part I: review of anticoagulation agents and clinical considerations: endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol 30:1155–1167

    Article  Google Scholar 

  9. Palsson R, Short SA, Kibbelaar ZA, Amodu A, Stillman IE, Rennke HG, McMahon GM, Waikar SS (2020) Bleeding complications after percutaneous native kidney biopsy: results from the boston kidney biopsy cohort. Kidney Int Rep 5:511–518

    Article  Google Scholar 

  10. Schorr M, Roshanov PS, Weir MA, House AA (2020) Frequency, timing, and prediction of major bleeding complications from percutaneous renal biopsy. Can J Kidney Health Dis 7:2054358120923527

    Article  Google Scholar 

  11. Mejía-Vilet JM, Márquez-Martínez MA, Cordova-Sanchez BM, Ibargüengoitia MC, Correa-Rotter R, Morales-Buenrostro LE (2018) Simple risk score for prediction of haemorrhagic complications after a percutaneous renal biopsy. Nephrology 23(6):523–529

    Article  Google Scholar 

  12. Whittier WL, Sayeed K, Korbet SM (2016) Clinical factors influencing the decision to transfuse after percutaneous native kidney biopsy. Clin Kidney J 9(1):102–107

    Article  CAS  Google Scholar 

  13. Escolar G, Garrido M, Mazzara R, Castillo R, Ordinas A (1988) Experimental basis for the use of red cell transfusion in the management of anemic-thrombocytopenic patients. Transfusion 28(5):406–411

    Article  CAS  Google Scholar 

  14. Pavord S, Myers B (2011) Bleeding and thrombotic complications of kidney disease. Blood Rev 25(6):271–278

    Article  Google Scholar 

  15. Luciano RL, Moeckel GW (2019) Update on the native kidney biopsy: core curriculum 2019. Am J Kidney Dis 73(3):404–415

    Article  Google Scholar 

  16. Patel IJ, Rahim S, Davidson JC, Hanks SE, Tam AL, Walker TG, Wilkins LR, Sarode R, Weinberg I (2019) Society of Interventional Radiology Consensus Guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous image-guided interventions—part II: recommendations: endorsed by the Canadian Association for Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol 30(08):1168–11840

    Article  Google Scholar 

  17. Nagrebetsky A, Al-Samkari H, Davis N, Kuter D, Wiener-Kronish J (2019) Perioperative thrombocytopenia: evidence, evaluation, and emerging therapies. Br J Anaesth 122(1):19–31

    Article  CAS  Google Scholar 

  18. Chunduri S, Whittier WL, Korbet SM (2015) Adequacy and complication rates with 14-vs 16-gauge automated needles in percutaneous renal biopsy of native kidneys. Seminars in dialysis: 2015. Wiley Online Library, pp E11–E14

    Google Scholar 

  19. Wong P, Johnson KJ, Warner RL, Merz SI, Kruger GH, Weitzel WF (2013) Performance of biopsy needle with therapeutic injection system to prevent bleeding complications. J Med Dev 7(1):110021–110027

    Google Scholar 

  20. Rahal Junior A, Falsarella PM, Ferreira VTR, Mariotti GC (2018) Queiroz MRGd, Garcia RG: Injecting hemostatic matrix in the path of biopsies: efficacy, potential complications, and the management of such complications. Radiol Bras 51(2):102–105

    Article  Google Scholar 

Download references

Funding

This research did not receive funding.

Author information

Authors and Affiliations

  1. Department of Renal Medicine, Singapore General Hospital, Academia Level 3, 20 College Road, Singapore, 169856, Singapore

    Cynthia C. Lim, Ru Yu Tan, Jason C. J. Choo, Hui Zhuan Tan, Irene Mok, Yok Mooi Chin & Chieh Suai Tan

Authors
  1. Cynthia C. Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ru Yu Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jason C. J. Choo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hui Zhuan Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Irene Mok
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yok Mooi Chin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chieh Suai Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cynthia C. Lim.

Ethics declarations

Conflict of Interest

All authors declare no relevant conflict of interest.

Ethical approval

This study abided by the Declaration of Helsinki and waiver of informed consent for medical records review was approved by the local Institutional Review Board (CIRB E 2017/2647).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 57 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lim, C.C., Tan, R.Y., Choo, J.C.J. et al. Estimation of risk for major bleeding in native kidney biopsies in patients with multiple risk factors. Int Urol Nephrol 54, 343–348 (2022). https://doi.org/10.1007/s11255-021-02874-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-021-02874-y

Keywords

Search

Navigation